Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices

Laboratory Investigation - Tập 86 Số 3 - Trang 275-285 - 2006
Haude Clouzeau‐Girard1,2, Christelle Guyot1,2, Chantal Combe1,2, V. Moronvalle-Halley3, Chantal Housset4, Thierry Lamireau5,2, Jean Rosenbaum1,2, Alexis Desmoulière1,2
1IFR 66, Bordeaux, France
2INSERM E0362, Université Victor Segalen Bordeaux 2, Bordeaux, France
3Sanofi-Aventis, Alfortville, France
4INSERM U402, Université Pierre et Marie Curie Paris 6, Paris, France
5CHU Bordeaux, Hôpital des Enfants, Unité de Gastroentérologie Pédiatrique, Bordeaux, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

Schmucker, 1990, Hepatic injury induced by bile salts: correlation between biochemical and morphological events, Hepatology, 12, 1216, 10.1002/hep.1840120523

Poupon, 2000, Chronic cholestatic diseases, J Hepatol, 32, 129, 10.1016/S0168-8278(00)80421-3

Greim, 1973, Determination of bile acids in needle biopsies of human liver, Biochem Med, 8, 280, 10.1016/0006-2944(73)90032-X

Scholmerich, 1984, Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties—studies on isolated hepatocytes and lipid membrane vesicles, Hepatology, 4, 661, 10.1002/hep.1840040416

Sokol, 1993, Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes, Hepatology, 17, 869, 10.1002/hep.1840170518

Heuman, 1991, Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat, Gastroenterology, 100, 203, 10.1016/0016-5085(91)90602-H

Delzenne, 1992, Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo in vitro studies, Toxicol Lett, 61, 291, 10.1016/0378-4274(92)90156-E

Faubion, 1999, Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas, J Clin Invest, 103, 137, 10.1172/JCI4765

Lotersztajn, 2005, Hepatic fibrosis: molecular mechanisms and drug targets, Annu Rev Pharmacol Toxicol, 45, 605, 10.1146/annurev.pharmtox.45.120403.095906

Tuchweber, 1996, Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat, Lab Invest, 74, 265

Uchio, 2002, Cellular retinol-binding protein-1 expression and modulation during in vivo in vitro myofibroblastic differentiation of rat hepatic stellate cells and portal fibroblasts, Lab Invest, 82, 619, 10.1038/labinvest.3780456

Kinnman, 2003, The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis, Lab Invest, 83, 163, 10.1097/01.LAB.0000054178.01162.E4

Roberts, 1997, The pathobiology of biliary epithelia, Gastroenterology, 112, 269, 10.1016/S0016-5085(97)70244-0

Alpini, 1988, Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules, J Clin Invest, 81, 569, 10.1172/JCI113355

Marucci, 1993, Cell proliferation following extrahepatic biliary obstruction. Evaluation by immunohistochemical methods, J Hepatol, 17, 163, 10.1016/S0168-8278(05)80032-7

Slott, 1990, Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat, Gastroenterology, 99, 466, 10.1016/0016-5085(90)91030-A

Benedetti, 1997, Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver, Hepatology, 26, 9, 10.1002/hep.510260102

Desmoulière, 1997, Extracellular matrix deposition, lysyl oxydase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat, Lab Invest, 76, 765

Lerche-Langrand, 2000, Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology, Toxicology, 153, 221, 10.1016/S0300-483X(00)00316-4

Olinga, 2001, The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake, J Pharmacol Toxicol Methods, 45, 55, 10.1016/S1056-8719(01)00127-7

Olinga, 2001, Rat liver slices as a tool to study LPS-induced inflammatory response in the liver, J Hepatol, 35, 187, 10.1016/S0168-8278(01)00103-9

Neyrinck, 2005, Insight into the involvement of Kupffer cell-derived mediators in the hepatoprotective effect of glycine upon inflammation: study on rat precision-cut liver slices, Inflamm Res, 54, 106, 10.1007/s00011-004-1330-9

Verrill, 2002, Organotypic liver culture in a fluid-air interface using slices of neonatal rat and adult human tissue—a model of fibrosis in vitro, J Pharmacol Toxicol Methods, 48, 103, 10.1016/S1056-8719(03)00042-X

Vickers, 2004, Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis, Toxicol Sci, 82, 534, 10.1093/toxsci/kfh285

Van de Bovenkamp, 2005, Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu, Toxicol Sci, 85, 632, 10.1093/toxsci/kfi127

Moronvalle-Halley, 2005, Evaluation of cultured, precision-cut rat liver slices as a model to study drug-induced liver apoptosis, Toxicology, 207, 203, 10.1016/j.tox.2004.09.014

Wong, 1994, Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture, J Clin Invest, 94, 1563, 10.1172/JCI117497

Pinzani, 1994, Expression of platelet-derived growth factor in a model of acute liver injury, Hepatology, 19, 701, 10.1002/hep.1840190323

Pinzani, 1996, Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis, Am J Pathol, 148, 785

LeSage, 2001, Regulation of cholangiocyte proliferation, Liver, 21, 73, 10.1034/j.1600-0676.2001.021002073.x

Brown, 1992, Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces, Mol Biol Cell, 3, 1169, 10.1091/mbc.3.10.1169

Lorena, 2006, Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient mice, J Hepatol, 10.1016/j.jhep.2005.07.024

Borsi, 1987, Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells, J Cell Biol, 104, 595, 10.1083/jcb.104.3.595

Neaud, 2004, Thrombin up-regulates tissue factor pathway inhibitor-2 synthesis through a cyclooxygenase-2-dependent, epidermal growth factor receptor-independent mechanism, J Biol Chem, 279, 5200, 10.1074/jbc.M306679200

Fickert, 2005, Oncosis represents the main type of cell death in mouse models of cholestasis, J Hepatol, 42, 378, 10.1016/j.jhep.2004.10.016

Lamireau, 2003, Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion, Life Sci, 72, 1401, 10.1016/S0024-3205(02)02408-6

Heuman, 1996, Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection, J Lipid Res, 37, 562, 10.1016/S0022-2275(20)37599-4

Serini, 1998, The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1, J Cell Biol, 142, 873, 10.1083/jcb.142.3.873

Marra, 1998, Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration, Am J Pathol, 152, 423

Grappone, 1999, Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats, J Hepatol, 31, 100, 10.1016/S0168-8278(99)80169-X

Milani, 1991, Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease, Am J Pathol, 139, 1221

Lamireau, 1999, Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy, J Hepatol, 31, 248, 10.1016/S0168-8278(99)80221-9

Sedlaczek, 2001, Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis, Am J Pathol, 158, 1239, 10.1016/S0002-9440(10)64074-6

Bataller, 2005, Liver fibrosis, J Clin Invest, 115, 209, 10.1172/JCI24282

Valente, 1988, Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture, Biochemistry, 27, 4162, 10.1021/bi00411a039

Carr, 1994, Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant, Proc Natl Acad Sci USA, 91, 3652, 10.1073/pnas.91.9.3652

Marra, 1999, Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells, Hepatology, 29, 140, 10.1002/hep.510290107

Pinzani, 1989, Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells, J Clin Invest, 84, 1786, 10.1172/JCI114363

Win, 1993, Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor, Hepatology, 18, 137, 10.1002/hep.1840180121

Paradis, 2002, Effects and regulation of connective tissue growth factor on hepatic stellate cells, Lab Invest, 82, 767, 10.1097/01.LAB.0000017365.18894.D3

Fiorucci, 2004, The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis, Gastroenterology, 127, 1497, 10.1053/j.gastro.2004.08.001

Svegliati-Baroni, 2005, Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor, Gastroenterology, 128, 1042, 10.1053/j.gastro.2005.01.007

Guyot, 2006, Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved, Int J Biochem Cell Biol, 38, 135

Li, 2004, The pathology of cholestasis, Semin Liver Dis, 24, 21, 10.1055/s-2004-823099